Skip to main content
. 2022 Feb;11(2):201–212. doi: 10.21037/tlcr-22-49

Figure 1.

Figure 1

Study flow diagram. NSCLC, non-small-cell lung cancer; ICI, immune checkpoint inhibitor; EGFR, epithelial growth factor receptor; ALK, anaplastic lymphoma kinase; ECOG, Eastern Cooperative Oncology Group.